Clinical Trials Logo

Hemodynamic Management clinical trials

View clinical trials related to Hemodynamic Management.

Filter by:
  • None
  • Page 1

NCT ID: NCT05149196 Not yet recruiting - Acute Kidney Injury Clinical Trials

Goal-directed Hemodynamic Management and Acute Kidney Injury After Radical Nephrectomy

Start date: December 2022
Phase: N/A
Study type: Interventional

Radical nephrectomy is a standard operation for the treatment of renal cell carcinoma. However, acute kidney injury frequently occur after surgery. And the occurrence of acute kidney injury is associated with an increased risk of chronic kidney disease. Intraoperative hypotension is identified as an important risk factor of postoperative acute kidney injury. Preliminary studies showed that goal-directed hemodynamic management may reduce organ injury after surgery but requires further demonstration. We hypothesized that goal-directed hemodynamic therapy achieved by combining liquid therapy and vasopressors can reduce the incidence of acute kidney injury after radical nephrectomy. The purpose of this study was to investigate the effect of goal-directed hemodynamic management on the incidence of acute kidney injury in patients following radical nephrectomy.

NCT ID: NCT03208023 Terminated - Clinical trials for Fluid Responsiveness

RESIPI for Reducing Perioperative Major Adverse Cardiac Events

RESIPI
Start date: October 9, 2017
Phase: N/A
Study type: Interventional

This study aims to evaluate the effect of a novel hemodynamic management and monitoring strategy for reducing cardiac bio marker elevations and major adverse cardiac events.